← Open Payments lookup

RANDON JENKINS: Open Payments

NPI 1093217218 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,069 in 21 payments from 13 companies in 2025. Trend: 2023 $139 · 2024 $444 · 2025 $1,069

Food & beverage: $1,069
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$289
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$180
Astellas Pharma US Inc1$126
Phathom Pharmaceuticals, Inc.1$116
Janssen Pharmaceuticals, Inc1$99
Dexcom, Inc.2$82
Neurocrine BioSciences, Inc.1$49
Xeris Pharmaceuticals, Inc.2$44
Sumitomo Pharma America, Inc.1$19
Bayer Healthcare Pharmaceuticals Inc.1$17

Products named: BREZTRI, CAPLYTA, Veozah, VOQUEZNA, INVEGA SUSTENNA, INGREZZA, DEXCOM G7 GSS (161), GVOKE HYPOPEN.

Industry payments across MI — which companies pay providers there.